An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

Newman, Aaron M, Bratman, Scott V, To, Jacqueline, Wynne, Jacob F, Eclov, Neville C W, Modlin, Leslie A, Liu, Chih Long, Neal, Joel W +6 more·2014·Nature Medicine

DOI 10.1038/nm.3519

Cited by (1,002)

Items 301–400 of 1,002

Monitoring Tumor Burden in Response to FOLFIRINOX Chemotherapy Via Profiling Circulating Cell-Free DNA in Pancreatic Cancer
Tao Wei, Qi Zhang, Xiang Li, Wei Su, Guogang Li, Tao Ma, Shunliang Gao, Jianying Lou, Risheng Que, Lei Zheng et al. · 2018 · Molecular Cancer Therapeutics
HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA
Eric Leung, Kathy Chai-Zung Han, Jinfeng Zou, Zhen Zhao, Yangqiao Zheng, Ting Ting Wang, Ariana Rostami, Lillian L. Siu, Trevor J. Pugh, Scott Victor Bratman · 2021 · Clinical Cancer Research
Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches
Francesco Cortiula, Bart J.T. Reymen, Solange Peters, Pierre Van Mol, Els Wauters, Johan Vansteenkiste, Dirk De Ruysscher, Lizza E.L. Hendriks · 2022 · Annals of Oncology
Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform
Evelyn Kidess, Kyra Heirich, Matthew Wiggin, Valentina S. Vysotskaia, Brendan Christopher Visser, Andre Marziali, Bertram J. Wiedenmann, Jeffrey Allen Norton, Mark Lee, Stefanie S. Jeffrey et al. · 2014 · Oncotarget
Circulating Tumor DNA: Measurement and Clinical Utility
Joshua M. Donaldson, Ben Ho Park · 2017 · Annual Review of Medicine
ESR1 mutations: Moving towards guiding treatment decision-making in metastatic breast cancer patients
Lindsay Angus, Nick Beije, Agnes Jager, John W.M. Martens, Stefan Sleijfer · 2016 · Cancer Treatment Reviews
Molecular profiling of single circulating tumor cells from lung cancer patients
Seung-min Park, Dawson J. Wong, Chin Chun Ooi, David Matthew Kurtz, Ophir Vermesh, Amin Aalipour, Susie Suh, Kelsey L. Pian, Jacob J. Chabon, Sang Hun Lee et al. · 2016 · Proceedings of the National Academy of Sciences
Update on the types and usage of liquid biopsies in the clinical setting: a systematic review
Borros Michael Arneth · 2018 · BMC Cancer
Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring
Iris Lodewijk, Marta Dueñas, Carolina Rubio, Ester Munera-Maravilla, Cristina Segovia, Alejandra Bernardini, Alicia Teijeira, Jesús María Paramio, Cristian Suárez-Cabrera · 2018 · International Journal of Molecular Sciences
Biophysicochemical Motifs in T-cell Receptor Sequences Distinguish Repertoires from Tumor-Infiltrating Lymphocyte and Adjacent Healthy Tissue
Jared Ostmeyer, Scott Christley, Inimary T. Toby, Lindsay Grey Cowell · 2019 · Cancer Research
Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and Screening
Jacob J. Adashek, Filip Jankú, Razelle Kurzrock · 2021 · Cancers
Incorporating blood-based liquid biopsy information into cancer staging: time for a TNMB system?
Mei Yang, M. Elizabeth Forbes, Rhonda Lynn Bitting, Stacey S. O’Neill, P -C Chou, Ümit Topaloĝlu, Lance David Miller, Gregory A. Hawkins, Stefan C. Grant, Barry R. DeYoung et al. · 2017 · Annals of Oncology
Circulating tumor cells versus circulating tumor DNA in lung cancer—which one will win?
Silvia Calabuig Fariñas, Eloisa Jantus Lewintre, Alejandro Herreros‐Pomares, Carlos Camps · 2016 · Translational Lung Cancer Research
Circulating DNA Demonstrates Convergent Evolution and Common Resistance Mechanisms during Treatment of Colorectal Cancer
Alain Roger Thierry, Brice Pastor, Zhi-Qin Jiang, Αναστασία Κατσιαμπούρα, Christine Megerdichian Parseghian, Jonathan M. Loree, Michael James Overman, Cynthia Sánchez, Safia El Messaoudi, Marc Ychou et al. · 2017 · Clinical Cancer Research
Challenges and achievements of liquid biopsy technologies employed in early breast cancer
Alfonso Alba-Bernal, Rocío Lavado-Valenzuela, María Emilia Domínguez-Recio, Begoña Jiménez-Rodríguez, María Isabel Queipo‐Ortuño, Emilio Alba, Iñaki Comino‐Méndez · 2020 · EBioMedicine
Circulating Tumor DNA in Lymphoma: Principles and Future Directions
Mark J. Roschewski, Davide Rossi, David Matthew Kurtz, Ash A. Alizadeh, Wyndham Hopkins Wilson · 2021 · Blood Cancer Discovery
Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study
Nicolas Pécuchet, Eleonora Zonta, Audrey Didelot, Pierre Combe, Constance Thibault, Laure Gibault, Camille Lours, Yves Rozenholc, Valérie Taly, Pierre Laurent‐Puig et al. · 2016 · PLoS Medicine
Very early response of circulating tumour–derived DNA in plasma predicts efficacy of nivolumab treatment in patients with non–small cell lung cancer
Yuki Iijima, Yosuke Hirotsu, Kenji Amemiya, Yoshihiko Ooka, Hitoshi Mochizuki, Toshio Oyama, Takahiro Nakagomi, Yoshinori Uchida, Yoichi Kobayashi, Toshiharu Tsutsui et al. · 2017 · European Journal of Cancer
Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA)
Minji Lim, Chi‐Ju Kim, Vijaya Sunkara, Mi‐Hyun Kim, Yoon‐Kyoung Cho · 2018 · Micromachines
Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology
Laura Muinelo‐Romay, Carlos Casas‐Arozamena, Miguel Abal · 2018 · International Journal of Molecular Sciences
ESR/ERS statement paper on lung cancer screening
Hans‐Ulrich Kauczor, Anne‐Marie Baird, Torsten Gerriet Blum, Lorenzo Bonomo, Clementine Bostantzoglou, Otto Chris Burghuber, Blanka Čepická, Alina Comanescu, S. Couraud, Anand Devaraj et al. · 2020 · European Respiratory Journal
Preanalytical variables that affect the outcome of cell-free DNA measurements
Vida Ungerer, Abel Jacobus Bronkhorst, Stefan Holdenrieder · 2020 · Critical Reviews in Clinical Laboratory Sciences
Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study
Pradeep S. Chauhan, Kevin Yi Chen, Ramandeep K. Babbra, Wenjia Feng, Nadja Pejovic, Armaan Nallicheri, Peter K. W. Harris, Katherine Dienstbach, Andrew Atkocius, Lenon Maguire et al. · 2021 · PLoS Medicine
Circulating Tumor DNA Analysis for Liver Cancers and Its Usefulness as a Liquid Biopsy
Atsushi Ono, Akihiro Fujimoto, Yujiro Yamamoto, Sakura Akamatsu, Nobuhiko Hiraga, Michio Imamura, Tomokazu Kawaoka, Masataka Tsuge, Hiromi Abe, Clair Nelson Hayes et al. · 2015 · Cellular and Molecular Gastroenterology and Hepatology
Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer
F. Johannes P. van Valenberg, Andrew M. Hiar, Ellen Wallace, Julia A. Bridge, Donna J. Mayne, Safedin Beqaj, Wade Jeffers Sexton, Yair Lotan, Alon Z. Weizer, G. Kenneth Jansz et al. · 2018 · European Urology
Urinary detection of lung cancer in mice via noninvasive pulmonary protease profiling
Jesse D. Kirkpatrick, Andrew Warren, Ava P. Soleimany, Peter M.K. Westcott, Justin C. Voog, Carmen Martin-Alonso, Heather E. Fleming, Tuomas Tammela, Tyler Jacks, Sangeeta N. Bhatia · 2020 · Science Translational Medicine
Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors
Berland, Léa, Heeke, Simon, Humbert, Olivier, Macocco, Adam, Long-Mira, Elodie, Lassalle, Sandra, Lespinet-Fabre, Virginie, Lalvée, Salomé, Bordone, Olivier, Cohen, Charlotte et al. · 2019 · Journal of Thoracic Disease
EGFR mutations in lung cancer: from tissue testing to liquid biopsy
Francesca Fenizia, Antonella De Luca, Raffaella Pasquale, Alessandra Sacco, Laura Forgione, Matilde Lambiase, Alessia Iannaccone, Nicoletta Chicchinelli, Renato Franco, Antônio Rossi et al. · 2015 · Future Oncology
Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management
Julie A. Vendrell, Frédéric Tran Mau‐Them, Benoît Béganton, Sylvain Godreuil, Peter J. P. Coopman, Jérôme Solassol · 2017 · International Journal of Molecular Sciences
Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling
Vincent Plagnol, Samuel Woodhouse, Karen Howarth, Stefanie V. Lensing, Matt J. Smith, Michael Epstein, Mikidache Madi, Sarah Smalley, Catherine Leroy, Jonathan Hinton et al. · 2018 · PLoS ONE
At the dawn: cell-free DNA fragmentomics and gene regulation
Yaping Liu · 2021 · British Journal of Cancer
Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC
Shiou‐Hwei Yeh, Chiao‐Ling Li, You-Yu Lin, Ming‐Chih Ho, Ya-Chun Wang, Sheng-Tai Tseng, Pei‐Jer Chen · 2023 · Cellular and Molecular Gastroenterology and Hepatology
Molecular Analysis of Plasma From Patients With ROS1-Positive NSCLC
Ibiayi Dagogo‐Jack, Marguerite M. Rooney, Rebecca J. Nagy, Jessica J. Lin, Emily N. Chin, Lorin A. Ferris, Jennifer Ackil, Jochen K. Lennerz, Richard Burnham Lanman, Justin F. Gainor et al. · 2019 · Journal of Thoracic Oncology
Activity-Based Diagnostics: An Emerging Paradigm for Disease Detection and Monitoring
Ava P. Soleimany, Sangeeta N. Bhatia · 2020 · Trends in Molecular Medicine
Rapid and ultrasensitive electrochemical detection of circulating tumor DNA by hybridization on the network of gold-coated magnetic nanoparticles
Dongfei Chen, Yanfang Wu, Sharmin Hoque, Richard David Tilley, J. Justin Gooding · 2021 · Chemical Science
The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments
Daniel Di Capua, Dara Mark Bracken-Clarke, Karine E. Ronan, Anne‐Marie Baird, Stephen P. Finn · 2021 · Cancers
Cell-free DNA approaches for cancer early detection and interception
Jamie E. Medina, Nicholas C. Dracopoli, Peter Brian Bach, Anna Lau, Robert B. Scharpf, Gerrit A. Meijer, Claus L. Andersen, Victor E. Velculescu · 2023 · Journal for ImmunoTherapy of Cancer
Variant allele frequency: a decision-making tool in precision oncology?
Luca Boscolo Bielo, Dario Trapani, Matteo Repetto, Edoardo Crimini, Carmine Valenza, Carmen Belli, Carmen Criscitiello, Antonio Marra, Vivek Subbiah, Giuseppe Curigliano · 2023 · Trends in cancer
Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer
Bo Ai, Huiquan Liu, Yu Huang, Ping Peng · 2016 · Oncotarget
Liquid Biopsies for Cancer: Coming to a Patient near You
Nithya Krishnamurthy, Emily G. Spencer, Ali Torkamani, Laura J. Nicholson · 2017 · Journal of Clinical Medicine
ERBB2 -Mutated Metastatic Non–Small Cell Lung Cancer: Response and Resistance to Targeted Therapies
Jody C. Chuang, Henning Stehr, Ying Liang, Millie Snigdha Das, Jane Q. Huang, Maximilian Diehn, Heather A. Wakelee, Joel W. Neal · 2017 · Journal of Thoracic Oncology
Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients
Taylor J. Jensen, Aaron Michael Goodman, Shumei Kato, Christopher K. Ellison, Gregory A. Daniels, Lisa Kim, Prachi Nakashe, Erin McCarthy, Amin R. Mazloom, Graham McLennan et al. · 2018 · Molecular Cancer Therapeutics
Ultrasensitive Detection of Circulating Tumor DNA of Lung Cancer via an Enzymatically Amplified SERS-Based Frequency Shift Assay
Jie Zhang, Yuhang Dong, Wenfeng Zhu, Dan Xie, Yuliang Zhao, Dayong Yang, Min Li · 2019 · ACS Applied Materials & Interfaces
The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications
K. Anderson, D. Auclair, G. Kelloff, C. Sigman, H. Avet-Loiseau, A. Farrell, N. Gormley, Shaji K. Kumar, O. Landgren, N. Munshi et al. · 2017 · Clinical Cancer Research
Cancer DNA in the Circulation
Hatim Husain, Victor E. Velculescu · 2017 · JAMA
The Future of Radiobiology
David G. Kirsch, Max Diehn, Aparna Hemant Kesarwala, Amit M. Maity, Meredith Ann Morgan, Julie Kristina Schwarz, Robert Glen Bristow, Sandra Demaria, Iris Eke, Robert J. Griffin et al. · 2017 · JNCI Journal of the National Cancer Institute
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia
Fary Diop, Riccardo Moia, Chiara Favini, Elisa Spaccarotella, Lorenzo De Paoli, Alessio Bruscaggin, Valeria Spina, Lodovico Terzi di Bergamo, Francesca Arruga, Chiara Tarantelli et al. · 2019 · Haematologica
Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden
Guanhua Zhu, Yu Amanda Guo, Danliang Ho, Polly S. Y. Poon, Zhong Wee Poh, Pui‐Mun Wong, Anna Gan, Mei Mei Chang, Dimitrios Kleftogiannis, Yi Ting Lau et al. · 2021 · Nature Communications
Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research
Eliza Maria Lauer, Jurik Mutter, Florian Scherer · 2022 · Leukemia
Lung Cancer Screening Beyond Low-Dose Computed Tomography: The Role of Novel Biomarkers
Naveed Hasan, Rohit Kumar, Mani S. Kavuru · 2014 · Lung
Osteosarcoma, chondrosarcoma and Ewing sarcoma: clinical aspects, biomarker discovery and liquid biopsy
Aran, Veronica, Devalle, Sylvie, Meohas, Walter, Heringer, Manoela, Cunha Caruso, Anabela, Pinheiro Aguiar, Diego, Leite Duarte, Maria Eugênia, Moura Neto, Vivaldo · 2021 · Critical Reviews in Oncology/Hematology
Circulating-tumor DNA as an early detection and diagnostic tool
Timothy M. Butler, Paul T. Spellman, Joe W. Gray · 2017 · Current Opinion in Genetics & Development
Increased Plasma Circulating Cell-Free DNA Could Be a Potential Marker for Oral Cancer
Li-Han Lin, Kuo‐Wei Chang, Shou‐Yen Kao, Hui-Wen Cheng, Chung‐Ji Liu · 2018 · International Journal of Molecular Sciences
Circulating Tumor DNA Profiling of Advanced Biliary Tract Cancers
Kabir Mody, Pashtoon Murtaza Kasi, Ju-Dong Yang, Phani Keerthi Surapaneni, Tanios Bekaii‐Saab, Daniel H. Ahn, Amit Mahipal, Mohamad Bassam Sonbol, Jason Scott Starr, Ali Roberts et al. · 2019 · JCO Precision Oncology
Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer
Maria F. Arisi, Efrat Dotan, Sandra Viviana Fernandez · 2022 · International Journal of Molecular Sciences
Liquid biopsy for cancer: review and implications for the radiologist
Underwood, Jacob J., Quadri, Rehan S., Kalva, Sanjeeva P., Shah, Hriday, Sanjeeviah, Aravind R., Beg, Muhammad S., Sutphin, Patrick D. · 2020 · Radiology
Analysis of Base-Position Error Rate of Next-Generation Sequencing to Detect Tumor Mutations in Circulating DNA
Nicolas Pécuchet, Yves Rozenholc, Eleonora Zonta, Daniel Pietrasz, Audrey Didelot, Pierre Combe, Laure Gibault, Jean‐Baptiste Bachet, Valérie Taly, Elizabeth Fabre et al. · 2016 · Clinical Chemistry
Circulating Tumor DNA Assays in Clinical Cancer Research
Miguel R. Ossandon, Lokesh Agrawal, Eric J. Bernhard, Barbara A. Conley, Sumana M Dey, Rao L. Divi, Ping Guan, Tracy Lively, Tawnya C. McKee, Brian S. Sorg et al. · 2018 · JNCI Journal of the National Cancer Institute
Translating insights into tumor evolution to clinical practice: promises and challenges
Matthew W. Fittall, Peter Van Loo · 2019 · Genome Medicine
Liquid biopsy of circulating tumor DNA and biosensor applications
Xuanying Li, Mengsha Ye, Weiying Zhang, Duo Tan, Nicole J. Jaffrezic-Renault, Xu Yang, Zhenzhong Guo · 2018 · Biosensors and Bioelectronics
Potential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq
Scott Victor Bratman, Aaron M. Newman, Ash A. Alizadeh, Maximilian Diehn · 2015 · Expert Review of Molecular Diagnostics
High‐Performance Nucleic Acid Sensors for Liquid Biopsy Applications
Jagotamoy Das, Shana O. Kelley · 2019 · Angewandte Chemie International Edition
Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA
Jee‐Soo Lee, Sung Sup Park, Young Kyung Lee, Jeffrey Allen Norton, Stefanie S. Jeffrey · 2019 · Molecular Oncology
Biomarkers in Lung Cancer
Catherine R. Sears, Peter J. Mazzone · 2020 · Clinics in Chest Medicine
Advanced nanomaterials as sample technique for bio-analysis
Nianrong Sun, Hailong Yu, Hao Wu, Xizhong Shen, Chunhui Deng · 2021 · TrAC Trends in Analytical Chemistry
Liquid Biopsy Based on Cell-Free DNA and RNA
Conor Loy, Lauren S. Ahmann, Iwijn De Vlaminck, Wei Gu · 2024 · Annual Review of Biomedical Engineering
Microfluidic-based solid phase extraction of cell free DNA
Camila D. M. Campos, Sachindra S. T. Gamage, Joshua M. Jackson, Malgorzata Anna Witek, Daniel Sang-Won Park, Michael C. Murphy, Andrew K. Godwin, Steven A. Soper · 2018 · Lab on a Chip
Liquid biopsy for lung cancers: an update on recent developments
Alberto E. Revelo, Alvaro Martin, Ricardo Velasquez, Prarthna Chandar Kulandaisamy, Jean Bustamante, Sevak Keshishyan, Gregory A. Otterson · 2019 · Annals of Translational Medicine
KRASmutations in blood circulating cell-free DNA: a pancreatic cancer case-control
Florence Le Calvez‐Kelm, Matthieu Foll, Magdalena B. Wozniak, Tiffany Myriam Delhomme, Geoffroy Durand, Priscilia Chopard, Maroulio Pertesi, Eleonóra Fabiánová, Zora Kľocová Adamčáková, Ivana Holcátová et al. · 2016 · Oncotarget
Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer
Dana W.Y. Tsui, Muhammed Murtaza, Alvin Seng Cheong Wong, Oscar M. Rueda, Christopher G. Smith, Dineika Chandrananda, Ross Andrew Soo, Hong Liang Lim, Boon Cher Goh, Carlos Caldas et al. · 2018 · EMBO Molecular Medicine
Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact
Natasha Honoré, Rachel Galot, Cédric van Marcke, Nisha Limaye, Jean‐Pascal Machiels · 2021 · Cancers
Applications of DNA-Based Liquid Biopsy for Central Nervous System Neoplasms
Joanna Wang, Chetan Bettegowda · 2016 · Journal of Molecular Diagnostics
Role of circulating-tumor DNA analysis in non-small cell lung cancer
Tao Jiang, Shengxiang Ren, Caicun Zhou · 2015 · Lung Cancer
Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer
Catherine W. Bennett, Guy Berchem, Yeoun Jin Kim, Victoria El‐Khoury · 2016 · Oncotarget
Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM)
Herbert I. Hurwitz, Benjamin R. Tan, James Andrew Reeves, Henry Q. Xiong, Brad Somer, Heinz‐Josef Lenz, Howard S. Höchster, Frank A. Scappaticci, John F. Palma, Richard Price et al. · 2018 · The Oncologist
A ligation-based single-stranded library preparation method to analyze cell-free DNA and synthetic oligos
Christopher J. Troll, Joshua D. Kapp, Varsha Rao, Kelly M. Harkins, Charles Cole, Colin Naughton, Jessica M. Morgan, Beth Shapiro, Richard Edward Green · 2019 · BMC Genomics
Enabling Precision Oncology Through Precision Diagnostics
Noah A. Brown, Kojo S.J. Elenitoba‐Johnson · 2020 · Annual Review of Pathology Mechanisms of Disease
Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors
Lionel Larribère, Uwe M. Martens · 2021 · Cancers
Circulating Extracellular DNA: Cause or Consequence of Thrombosis?
Miguel Jiménez-Alcázar, Natalie Kim, Tobias A. Fuchs · 2017 · Seminars in Thrombosis and Hemostasis
Beyond the Blood: CSF-Derived cfDNA for Diagnosis and Characterization of CNS Tumors
Abbye E. McEwen, Sarah E. S. Leary, Christina M. Lockwood · 2020 · Frontiers in Cell and Developmental Biology
Cross-Platform Comparison of Four Leading Technologies for Detecting EGFR Mutations in Circulating Tumor DNA from Non-Small Cell Lung Carcinoma Patient Plasma
Ting Xu, Xiaozheng Kang, Xiaofang You, Liang Xiang Dai, Dequan Tian, Wanpu Yan, Yongbo Yang, Hongchao Xiong, Zhen Liang, Grace Zhao et al. · 2017 · Theranostics
High-throughput sequencing for noninvasive disease detection in hematologic malignancies
Florian Scherer, David Matthew Kurtz, Maximilian Diehn, Ash A. Alizadeh · 2017 · Blood
The use of technical replication for detection of low-level somatic mutations in next-generation sequencing
Junho Kim, Dachan Kim, Jae Seok Lim, Ju Heon Maeng, Hyeonju Son, Hoon‐Chul Kang, Hojung Nam, Jeong Ho Lee, Sangwoo Kim · 2019 · Nature Communications
The potential of cerebrospinal fluid-based liquid biopsy approaches in CNS tumors.
A. Mattox, Hai Yan, C. Bettegowda · 2019 · Neuro-Oncology
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma
Stefan Alig, Charles W. Macaulay, David Matthew Kurtz, Ulrich Dührsen, Andreas Hüttmann, Christine Schmitz, Michael Chuwei Jin, Brian J. Sworder, Andrea Garofalo, Mohammad Shahrokh Esfahani et al. · 2021 · Journal of Clinical Oncology
Biomarkers and Lung Cancer Early Detection: State of the Art
Elisa Dama, Tommaso Colangelo, Emanuela Fina, M. Cremonesi, Marinos Kallikourdis, Giulia Veronesi, Fabrizio Bianchi · 2021 · Cancers
Massively parallel enrichment of low-frequency alleles enables duplex sequencing at low depth
Gregory Gydush, Erica Nguyen, Jin H. Bae, Timothy Blewett, Justin Rhoades, Sarah C. Reed, Douglas Shea, Kan Xiong, Ruolin Liu, Fangyan Yu et al. · 2022 · Nature Biomedical Engineering
Enhancing clinical potential of liquid biopsy through a multi-omic approach: A systematic review
Gianna Di Sario, Valeria Rossella, Elvira Smeralda Famulari, Aurora Maurizio, Dejan Lazarević, Francesca Giannese, Claudia Felici · 2023 · Frontiers in Genetics
Liquid biopsy: Potential and challenges
Klaus Pantel, Catherine Alix‐Panabières · 2016 · Molecular Oncology
High-fidelity target sequencing of individual molecules identified using barcode sequences:de novodetection and absolute quantitation of mutations in plasma cell-free DNA from cancer patients
Yoji Kukita, Ryo Matoba, Junji Uchida, Takuya Hamakawa, Yuichiro� Doki, Fumio Imamura, Kikuya Kato · 2015 · DNA Research
Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing
Christina Demuth, Karen‐Lise Garm Spindler, Julia Sidenius Johansen, Niels Pallisgaard, Dorte Lisbet Nielsen, Estrid Vilma Solyom Høgdall, Benny Vittrup, Boe Sandahl Sørensen · 2018 · Translational Oncology
Distant Metastasis in Colorectal Cancer Patients—Do We Have New Predicting Clinicopathological and Molecular Biomarkers? A Comprehensive Review
Stanislav Filip, Veronika Polakova Vymetalkova, Jiřı́ Petera, Ľudmila Vodičková, Ondřej Kubeček, Stanislav John, Filip Čečka, Marketa Krupova, Monika Manethová, Klára Červená et al. · 2020 · International Journal of Molecular Sciences
In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin’s lymphoma and facilitates ultrasensitive residual disease detection
Sophia Sobesky, Laman Mammadova, Melita Cirillo, Esther E.E. Drees, Julia Mattlener, Helge Dörr, Janine Altmüller, Zhiyuan Shi, Paul Jan Bröckelmann, Jonathan M. Weiss et al. · 2021 · Med
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions
Rocı́o I.R. Macı́as, Vincenzo Cardinale, Timothy James Kendall, Matias Antonio Avila, Maria Guido, Cédric Coulouarn, Chiara Braconi, Adam Enver Frampton, John A. Bridgewater, Diletta Overi et al. · 2022 · Gut
Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society
Lynette Marie Sholl, Dara L. Aisner, Timothy Craig Allen, Mary Beth Beasley, Philip T. Cagle, Vera Luíza Capelozzi, Sanja Đačić, Lida P. Hariri, Keith M. Kerr, Sylvie Lantuéjoul et al. · 2016 · Archives of Pathology & Laboratory Medicine
BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System
Filip Jankú, Helen J. Huang, Bart Claes, Gerald Steven Falchook, Siqing Fu, David S. Hong, Nishma M. Ramzanali, Giovanni Nitti, Goran Cabrilo, Apostolia Maria Tsimberidou et al. · 2016 · Molecular Cancer Therapeutics
Cancer Biomarker Discovery for Precision Medicine: New Progress
Jinfeng Zou, Edwin Wang · 2018 · Current Medicinal Chemistry
Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes.
Xu Zhang, Si Shi, Bo Zhang, Quanxing Ni, Xianjun Yu, Jin Xu · 2018 · PubMed Central
Understanding Drug Sensitivity and Tackling Resistance in Cancer
Jeffrey W Tyner, Franziska Haderk, Anbarasu Kumaraswamy, Linda B. Baughn, Brian Van Ness, Song Liu, Himangi Marathe, Joshi J. Alumkal, Trever G. Bivona, Keith Syson Chan et al. · 2022 · Cancer Research
Role of Circulating Cell-Free DNA in Cancers
Aarthy Raghu, Samson Mani, Velusami Sridevi, Shirley Sundarsingh, Thangarajan Rajkumar · 2015 · Molecular Diagnosis & Therapy